NCT02039739已完成不适用
Evaluation of Effectiveness and Safety of Orsiro™ in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Seung-Jung Park18 个研究点 分布在 1 个国家目标入组 1,007 人开始时间: 2014年6月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,007
- 试验地点
- 18
- 主要终点
- Composite event rate
研究概览
简要总结
The purpose of this study is to evaluate effectiveness and safety of Orsiro™ Drug Eluting Stent in Routine Clinical Practice
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 20 and more
- •Intervention with Orsiro™ Drug Eluting Stent
- •Agreed with written informed consent form
排除标准
- •Intervention with Orsiro™ drug eluting coronary stent and other drug eluting stent at the same time
- •Life expectancy of 1year and under
- •Cardiac shock
结局指标
主要结局
Composite event rate
时间窗: 1YEAR
次要结局
- CARDIAC DEATH(5YEAR)
- Composite event of death or myocardial infarction(5YEAR)
- Target Vessel revascularization(5YEAR)
- Stroke(5YEAR)
- Composite event of cardiac death or myocardial infarction(5YEAR)
- Target Lesion revascularization(5YEAR)
- ALL DEATH(5YEAR)
- MYOCARDIAL INFARCTION(5YEAR)
- Procedural success(3day)
- Stent thrombosis(5YEAR)
研究者
Seung-Jung Park
MD,PhD
Asan Medical Center
研究点 (18)
Loading locations...
相似试验
终止
不适用
BIOFLOW-SV All Comers Registryde NovoSymptomatic Ischemic Heart DiseaseRestenoses, CoronaryNCT03600948Biotronik AG261
终止
不适用
BIOFLOW-SV Portugal RegistryIschemic Heart DiseaseNCT03600961Biotronik AG173
已完成
不适用
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery LesionsAtherosclerosis, CoronaryIschemic Heart DiseaseAcute Coronary SyndromeCoronary Artery DiseaseMyocardial IschemiaAngina PectorisNCT02389946Biotronik, Inc.1,334
已完成
不适用
BIOFLOW III Satellite-Italy Orsiro Stent SystemCoronary Artery DiseasesNCT02028728Biotronik Italia S.p.A.609
招募中
不适用
Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical PracticePercutaneous Transluminal Coronary AngioplastyCoronary Artery DiseaseNCT01186133Seung-Jung Park50,000